Aurobindo Pharma Ltd.’s first-quarter profit rose, in-line with analysts’ estimates.The Hyderabad-based bulk and generic drug maker’s net profit rose 10% year-on-year to Rs 571 crore in the quarter ended June, according to an exchange filing. That compares with the Rs 557-crore consensus estimate of analysts tracked by Bloomberg.Sequentially, it rose 13%.
The consumer discretionary space continues to reveal a mixed performance across segments, driven by gold prices, festive shifts, and evolving...
Sir Demis Hassabis is Co-Founder and CEO of Google DeepMind. He has won many prestigious international awards for his research work...
Fun trivia Q: If you were to bucket US stock market returns for the past 100...
This article was written byFollowProviding timely and quick to the punch analysis of earnings and macro-related events across various sectors,...
After multiple arrests, Florida officials are ramping up a criminal investigation of a marijuana multistate operator-funded adult-use cannabis legalization campaign...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
